Supplements

Rolled into one? Weeding out evidence on cognitive impact of marijuana from that of THC

THIS SUPPLEMENT IS SPONSORED BY GREENWICH BIOSCIENCES, INC.

 

Cannabis (also known as Marijuana), an umbrella term encompassing natural and bred plant varieties, contains over 100 distinct cannabinoids and other bioactive molecules in varying ratios, yet all are commonly conflated with the prime euphorigenic cannabinoid, Δ-9 etrahydrocannabinol (THC).1 A lack of appreciation for this distinction, along with media sensationalism, have created misinformation about the biological actions of specific cannabinoids, for instance, that regarding the cognitive impact of THC versus cannabis in general.

 

This supplement to Neurology Reviews summarizes summarize findings from English-only, peer-reviewed original articles and meta-analyses of specified cannabinoids’ effect on cognition in preclinical and clinical literature, where known, to guide practitioners with proper evidence and highlighting gaps in knowledge for future research.

Click here to read the supplement. 

 

Authors

Francesca Filbey, PhD
Bert Moore Chair and Professor
of Cognition and Neuroscience
The University of Texas at Dallas


Chris Hauser, PhD
Medical Science Liaison
Greenwich Biosciences, Inc.


Karthik Rajasekaran, PhD
Sr. Medical Science Liaison
Greenwich Biosciences, Inc.

 

1. Mead A. Front Plant Sci. 2019;10:697.

Recommended Reading

COVID-19 drives nursing homes to overhaul infection control efforts
MDedge Neurology
Age leads COVID-19 hospitalization risk factors in RMDs
MDedge Neurology
WHO clarifies comments on asymptomatic transmission of SARS-CoV-2
MDedge Neurology
Kids with food allergies the newest victims of COVID-19?
MDedge Neurology
Daily Recap: How to stay afloat financially during COVID-19, more bad news on e-cigs
MDedge Neurology
Money worries during COVID-19? Six tips to keep your finances afloat
MDedge Neurology
COVID-19: Where doctors can get help for emotional distress
MDedge Neurology
Assessing Spinal Muscular Atrophy Across the Patient Journey
MDedge Neurology
EULAR’s COVID-19 recommendations offer no surprises
MDedge Neurology
Clinicians urged to use CURE ID to report COVID-19 cases
MDedge Neurology